Market Outlook: Blood Collection and Transfusion Devices

According to FutureWise analysis the Blood Collection and Transfusion Devices Market in 2025 is 5.44 billion, and is expected to reach US$ 10.18 billion by 2033 at a CAGR of 8.15%. The market is experiencing growth due to rising demand for blood transfusions and a higher prevalence of chronic diseases. Advanced automated and smart transfusion technologies are improving safety and efficiency. Additionally, expanding healthcare infrastructure and increased awareness of safe blood collection practices are driving the need for innovative blood collection and transfusion devices worldwide.

Blood collection and transfusion devices are essential tools in modern healthcare, playing a crucial role in the safe and efficient collection, processing, storage, and administration of blood and its components. These devices are vital for various medical procedures, including surgeries, trauma care, cancer treatments, and the management of blood disorders such as anemia and hemophilia. By ensuring hygienic collection, proper storage, and safe transfusion of blood, these devices help minimize risks such as infections, transfusion reactions, and contamination.

Key components of blood collection include needles, vacuum tubes, blood bags, and lancets, all specifically designed to collect blood from donors or patients with precision and minimal discomfort. Vacuum tubes are commonly used for collecting diagnostic samples, while blood bags treated with anticoagulants help preserve whole blood or specific components like plasma, red blood cells, and platelets for transfusion. Additionally, advanced technologies like apheresis machines enable the selective collection of particular blood components, enhancing efficiency and improving patient outcomes.

Transfusion devices, including IV catheters, infusion pumps, and blood warmers, are critical for the safe delivery of blood products to patients. Infusion pumps control the flow rate to minimize complications such as fluid overload, while blood warmers ensure that blood products are administered at optimal temperatures, preventing hypothermia during transfusion. These devices are equipped with safety features to guarantee compatibility, sterility, and accurate delivery.

The development of blood collection and transfusion devices has been driven by advancements in materials science, automation, and infection control measures, significantly reducing human error and enhancing patient safety. Regulatory bodies, such as the FDA and WHO, impose strict standards to ensure that these devices meet high-quality and safety requirements. As healthcare demands continue to evolve, innovations in blood collection and transfusion technologies are expected to further improve their efficiency, accessibility, and safety, thus playing a vital role in saving lives and supporting medical care globally.

FutureWise Market Research has published a report that provides an insightful analysis of Blood Collection and Transfusion Devices Market trends that are affecting the overall market growth.

Request a Free Sample @  https://www.futurewiseresearch.com/contact.aspx?rpt=71&type=requestsample

Blood Collection and Transfusion Devices Market Segmentation:

By Product Type

• Blood Collection Tubes
• Needles and Syringes
• Vacuum Blood Collection System
• Non-vacuum Blood Collection System
• Microfluidic devices
• Blood collection and Storage Bags

By Blood Component

• Whole Blood
• Plasma
• RBC
• Others

By End-User

• Hospitals
• Blood Banks
• Cord Blood Banks
• Medical Institutes
• Community Health Centres
• Clinics
• Ambulatory Centres

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Blood Collection and Transfusion Devices Market:

• SARSTEDT AGCo. KG
• Becton Dickinson
• Medtronic
• Terumo Corp
• Greiner Bio One International GmbH
• Abbott
• NIPRO Medical Corporation
• QIAGEN
• FL Medical s.r.l.
• Haemonetics Corporation
• F. Hoffmann-La Roche Ltd.
• Centogene N.V.
• SEKISUI CHEMICAL CO., LTD.

Recent developments by key players in Blood Collection and Transfusion Devices Market:

Haemonetics Corporation

In February 2025, Haemonetics sold its whole-blood assets to GVS S.p.A for USD 67.8 million, reallocating resources to enhance its apheresis capabilities.

Becton Dickinson

• In April 2024, during its launch in India, the Vacutainer UltraTouch Push Button system was unveiled, featuring RightGauge and PentaPoint technologies designed to lower insertion pain and reduce the risk of needlestick injuries by as much as 88%.
• In November 2023, the PIVO Pro was introduced—a device that allows for blood samples to be taken directly from IV lines without needles, aiming to minimize needle usage and enhance patient comfort.

Terumo Corp

• 2023–2024: Ongoing investments in cutting-edge apheresis technology, particularly the Reveos Automated Blood Processing System, which is the first innovative one-cycle whole blood separator now being introduced in the U.S.
• February 2024: Announced the expansion of its facility in Colorado to enhance production capabilities for collection and processing systems.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=71&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Blood Collection and Transfusion Devices Market By Product Type, By Blood Component, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com

Article source: https://article-realm.com/article/Health-Fitness/77467-Market-Outlook-Blood-Collection-and-Transfusion-Devices.html